European Peptide Manufacturers

Premium peptide synthesis hubs in Germany, Switzerland, and France. Known for precision manufacturing, ISO certification, and robust EU-wide distribution networks. Swiss CDMOs including Bachem (Bubendorf headquarters, CHF 605.3M revenue in 2024) and Lonza (Visp peptide operations) represent the largest concentration of peptide manufacturing capacity in Europe. The EMA's Guideline on the Development and Manufacture of Synthetic Peptides (EMA/CHMP/CVMP/QWP/367182/2025) took effect June 1, 2026, establishing the first EU-wide quality framework specifically for synthetic peptides with requirements for orthogonal purity methods, impurity profiling to 0.1% thresholds, and tiered acceptance criteria by peptide length and route of administration. Germany hosts CordenPharma which recently acquired AmbioPharm for a three-continent manufacturing footprint, along with Wacker Chemie and Fresenius Kabi.

Directory listing last reviewed August 2026.